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in Transplanted Mesenchymal Stromal CellsPeter J. Psaltis, MBBS, PHD,* Karen M. Peterson, BSC,* Rende Xu, MD,*
Federico Franchi, PHD,* Tyra Witt, CVT,* Ian Y. Chen, MD, PHD,y Amir Lerman, MD,*
Robert D. Simari, MD,* Sanjiv S. Gambhir, MD, PHD,z Martin Rodriguez-Porcel, MD*
Rochester, Minnesota; and Stanford, CaliforniaOBJECTIVES The goal of this study was to validate a pathway-speciﬁc reporter gene that could be
used to noninvasively image the oxidative status of progenitor cells.
BACKGROUND In cell therapy studies, reporter gene imaging plays a valuable role in the
assessment of cell fate in living subjects. After myocardial injury, noxious stimuli in the host tissue
confer oxidative stress to transplanted cells that may inﬂuence their survival and reparative function.
METHODS Rat mesenchymal stromal cells (MSCs) were studied for phenotypic evidence of increased
oxidative stress under in vitro stress. On the basis of their up-regulation of the pro-oxidant enzyme p67phox
subunit of nicotinamide adenine dinucleotide phosphate (NAD[P]H oxidase p67phox), an oxidative stress
sensor was constructed, comprising the ﬁreﬂy luciferase (Fluc) reporter gene driven by the NAD(P)H
p67phox promoter. MSCs cotransfected with NAD(P)H p67phox–Fluc and a cell viability reporter gene
(cytomegalovirus–Renilla luciferase) were studied under in vitro and in vivo pro-oxidant conditions.
RESULTS After in vitro validation of the sensor during low-serum culture, transfected MSCs were
transplanted into a rat model of myocardial ischemia/reperfusion (IR) and monitored by using
bioluminescence imaging. Compared with sham controls (no IR), cardiac Fluc intensity was signiﬁcantly
higher in IR rats (3.5-fold at 6 h, 2.6-fold at 24 h, 5.4-fold at 48 h; p < 0.01), indicating increased cellular
oxidative stress. This ﬁnding was corroborated by ex vivo luminometry after correcting for Renilla
luciferase activity as a measure of viable MSC number (Fluc:Renilla luciferase ratio 0.011  0.003 for
sham vs. 0.026  0.004 for IR at 48 h; p < 0.05). Furthermore, in IR animals that received MSCs
preconditioned with an antioxidant agent (tempol), Fluc signal was strongly attenuated, substantiating
the speciﬁcity of the oxidative stress sensor.
CONCLUSIONS Pathway-speciﬁc reporter gene imaging allows assessment of changes in the
oxidative status of MSCs after delivery to ischemic myocardium, providing a template to monitor key
biological interactions between transplanted cells and their host environment in living
subjects. (J Am Coll Cardiol Img 2013;6:795–802) ª 2013 by the American College of Cardiology
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796rogenitor cell therapies are being developed
as a therapeutic alternative for myocardial
repair in coronary artery disease (1). Al-
though studies have shown an overall beneﬁt
with improvements in left ventricular (LV) cardiac
function after myocardial injury, the beneﬁcial effect
of cell-based intervention after myocardial injury has
been modest, likely due to poor survival of trans-
planted cells (2). Until recently, progenitor cell
studies were limited in their capacity to assess cell
survival, both in cell culture and living subjects.See page 803Assessment of the fate and biology of cells after
transfer to recipient myocardium relied on tradi-
tional ex vivo assays and molecular techniques (e.g.,ging
al cell
phate
cies
nalhistology, western blotting), which are
both invasive and restricted in their ca-
pacity to monitor temporal changes in a
given subject. However, developments in
molecular imaging techniques, such as re-
porter gene technology, have increasingly
enabled the noninvasive surveillance of cell
fate after cardiovascular application (3).
Bioluminescent imaging (BLI) has pro-
vided helpful information in small animal
models regarding the kinetics of cell
viability by detecting transgene expression
under constitutional promoters in living
cells (4). Recent studies have demonstrated
that reporter gene imaging can also be used
to monitor biological processes, in addition
to cellular viability, by using conditionaltransgenes whose expression is regulated by
pathway-speciﬁc promoters (5,6).
In the setting of cell delivery after myocardial
infarction or ischemia/reperfusion (IR), the recipient
microenvironment may confer a heightened state of
oxidative stress to transplanted cells. Depending on
both cell type and degree of oxidative stress, this may
have adaptive or maladaptive effects on cell survival and
biological function, ultimately inﬂuencing capacity for
repair and/or regeneration (7–9). The ability to assess
the biological interactions of transplanted cells with
their host milieu in vivo, including their pro-oxidant
status, could provide invaluable insights to assist with
efforts to optimize stem cell functionality and thera-
peutic efﬁcacy (10). Here we report on the novel use of
conditional reporter gene labeling and imaging to
monitor oxidative stress in mesenchymal stromal cells(MSCs) after their in vivo delivery to a rodent model of
myocardial IR.
METHODS
Detailed methods are provided in the Online
Appendix. Bone marrow MSCs from rats were
phenotypically characterized under in vitro condi-
tions of increased oxidative stress. DNA reporter
gene plasmids were designed, constructed, and used
to transfect MSCs to enable assessment of oxidative
stress signal. This involved using ﬁreﬂy luciferase
(Fluc) driven by the promoter for the p67phox sub-
unit of nicotinamide adenine dinucleotide phos-
phate (NAD[P]H p67phox–Fluc). To overcome the
low expression levels typically inherent with tran-
scriptional targeting of reporter genes, signal
ampliﬁcation was achieved by a recently validated
2-step transcriptional ampliﬁcation (TSTA) strat-
egy (11). The oxidant signal was normalized to the
number of viable cells, assessed by using Renilla
luciferase under the regulation of a constitutive
cytomegalovirus promoter (CMV-Rluc). Trans-
fected cells were transplanted to animals after IR
(n ¼ 7) and compared with sham controls (n ¼ 8).
Furthermore, the oxidative stress sensor was also
evaluated in MSCs that had been pretreated with an
antioxidant (n ¼ 5).
Statistical comparisons were performed with
parametric or nonparametric 2-sample Student t
tests or 1-way analysis of variance (with Bonferroni
posttest comparison), as appropriate. Results are
expressed as mean  SEM of multiple experiments.
In all cases, statistical signiﬁcance was established at
2-tailed p < 0.05.
RESULTS
Reporter gene detection of cellular oxidative stress
in vitro. Initially, MSCs were assessed for their
susceptibility to increased oxidative stress under
in vitro stressors. After exposure to hypoxia (12) or
low-serum culture for 24 h (2% fetal bovine serum
[FBS]), MSCs displayed increased oxidative
stress conversion of 2070-dichlorodihydroﬂuorescein
diacetate (H2DCFDA) to 20,70-dichloroﬂuorescein,
compared with control conditions (10% FBS)
(2.9-fold difference; p < 0.05) (Fig. 1A). Both
conditions stimulated differences in MSC expres-
sion of various proteins involved in producing or
scavenging reactive oxygen species (ROS), including
up-regulation of the p67phox regulatory subunit of
Figure 1. Detection of Oxidative Stress in MSCs In Vitro
(A) Conversion of 2070-dichlorodihydroﬂuorescein diacetate (H2DCFDA) to 20 ,70-dichloroﬂuorescein (DCF) (measure of oxidative stress) in
mesenchymal stromal cells (MSCs) after culture in normal (10% fetal bovine serum [FBS]) or low (2% FBS) serum media for 24 h. RFU ¼ relative
ﬂuorescence units. (B) Densitometric analysis from immunoblotting of MSC lysates for the p67phox subunit of nicotinamide adenine
dinucleotide phosphate (NAD[P]H p67phox), corrected for beta-actin. (C) Oxidative stress plasmid vector NAD(P)H p67phox–ﬁreﬂy luciferase
(Fluc). Gal4-VP2 ¼ fusion gene combining yeast Gal4 and 2 tandem repeats of herpes simplex virus VP16; E4 ¼ adenovirus E4 minimal
promoter; PA ¼ SV40 poly(A) tail; TSTA ¼ 2-step transcription ampliﬁcation. (D) Bioluminescence imaging and (E) luminometry of Fluc activity
(oxidative stress signal) corrected for Renilla luciferase (Rluc; viable cell number) in MSCs under different culture conditions. Values are mean
 SEM. *p < 0.05, zp < 0.001. (F) There was strong correlation (R2 ¼ 0.95, p < 0.01) between Fluc activity and oxidative stress (by H2DCFDA
conversion) for MSCs cultured at varying serum concentrations (0.5%, 1%, 2%, 5%, and 10%). RLU ¼ relative light units.
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797NAD(P)H oxidase (Fig. 1B) (12). On this basis, a
transfection plasmid was designed for an oxidative
stress sensor that comprised the NAD(P)H p67phox
promoter (353bp, PubMed nucleotide DQ662934)
to regulate expression of the Fluc reporter gene
(Fig. 1C). Cells were cotransfected with the
CMV-Rluc and NAD(P)H p67phox–Fluc plasmids.
After 24 hours of culture in low-serum media,
MSC Fluc signal, corrected for cell number and
transfection efﬁciency, was signiﬁcantly increased
compared with control conditions, as shown inde-
pendently by BLI using a cooled charge-coupled
device camera (1.6-fold difference; p < 0.05)
(Fig. 1D) and luminometry (1.8-fold difference;
p < 0.05) (Fig. 1E). In further experiments, MSC
Fluc activity correlated strongly with oxidative stress
readout in response to varying concentrations ofFBS (R2 ¼ 0.95, p < 0.01) (Fig. 1F). Importantly,
MSCs pretreated with tempol, a superoxide
dismutase mimetic (4-hydroxy-2,2,6,6-tetramethyl
piperidinoxyl; 5 mmol/l) displayed a markedly
lower Fluc:Rluc signal ratio after low-serum culture,
compared with untreated cells (9.5  2.1 vs. 49.6 
6.4, respectively; p < 0.001) (Fig. 1E). These
in vitro results demonstrated that reporter genes,
under the regulation of the NAD(P)H p67phox
promoter, can be used to assess the oxidant status of
MSCs across a range of oxidative stress levels.
In vivo monitoring of oxidative stress in MSCs. We
then tested the oxidative stress sensor in a ratmodel of
anterior wall IR (30-min ischemia). Over the ﬁrst
week after IR surgery, ischemic myocardium dis-
played histological changes of progressive inﬂam-
matory cell inﬁltration and collagen deposition
Figure 2. Injurious Changes in Rat Myocardium After IR
(A) Hematoxylin-eosin, (B)Masson’s trichrome, and (C) immunohistochemical staining for 8-hydroxy-2’-deoxyguanosine (OHG) of the ischemic
territory in rats at different intervals after ischemia/reperfusion (IR) surgery (20 magniﬁcation). Yellow arrows, inﬂammatory cell inﬁltrates;
arrowhead, collagen; black arrows,OHG. (D) Percent area of OHG staining in ischemic myocardium at different intervals after IR; n$ 3 for each
time. (E) Expression bands of inﬂammatory, survival, and oxidative stress proteins from lysates of ischemic (or sham) myocardium at different
intervals after IR. For quantitative analysis, refer to Online Figure 1A. NF-kb ¼ nuclear factor kappa-light-chain-enhancer of activated B cells;
Bcl-2¼ B-cell lymphoma 2; Bax¼ bcl-2 associated X-protein; XDH¼ xanthine dehydrogenase; HO-1¼ heme oxygenase-1; SOD1¼ copper/zinc
superoxide dismutase; SOD2 ¼ manganese superoxide dismutase. (F) Echocardiographic results for end-diastolic volume (EDV), end-systolic
volume (ESV), and ejection fraction (EF) 2 days after IR or sham surgery; n¼ 4/group. Values are mean SEM. *p< 0.05, yp< 0.01 versus sham.
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798(Figs. 2A and 2B), with incremental expression of
8-hydroxy-2’-deoxyguanosine, a marker of oxidative
stress, that was prominent by 48 h (p< 0.05 vs. sham)
(Figs. 2C and 2D). Immunoblotting of myocardial
lysates revealed up-regulation of markers/mediatorsof inﬂammatory (nuclear factor kappa-light-chain-
enhancer of activated B cells), apoptotic (bcl-2 asso-
ciated X-protein), and oxidative stress pathways
(NAD[P]H p67phox, xanthine dehydrogenase, heme
oxygenase) in the ischemic and peri-ischemic tissue
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799compared with remote and sham myocardium, espe-
cially from day 2 after surgery (Fig. 2E,Online Fig. 1).
At this time point, there was also echocardiographic
evidence of reduced systolic function (ejection
fraction 49.3 4.9% for IR vs. 75.4 1.1% for sham;
p < 0.05) (Fig. 2F). Therefore, this model of IR
produced early injurious changes that would be ex-
pected to create a stressful milieu for cells trans-
planted into the anterior LV myocardium.
Next, allogeneic MSCs (7.5  105) cotransfected
with CMV-Rluc and NAD(P)H p67phox–Fluc were
administered transepicardially into the ischemic
territory of rats, 10 min after reperfusion, or sham
surgery. Bioluminescence imaging was performed
at 6, 24, and 48 h to detect Fluc activity after
administration of its substrate, D-luciferin. Fluc
signal was present at low levels over the heart and
lungs in sham controls at 6 h, indicating low-grade
stress experienced by MSCs early after injection
into nonischemic myocardium and prompt redistri-
bution of cells to the lungs (Online Fig. 2A). By
comparison, an intense Fluc signal was detectedFigure 3. Reporter Gene Detection of Oxidative Stress in MSCs In V
(A) Representative bioluminescence images for Fluc signal, 2 days after M
radiance of cardiac Fluc signal as determined by bioluminescence at d
luminometry, corrected for Rluc activity. Values are mean  SEM. IR, n
*p < 0.05 and yp < 0.01 versus IR animals treated with NAD(P)H p67phox
p67phox (red) by green ﬂuorescent protein (GFP) MSCs (green) retained
bottom left: higher magniﬁcation of inset box; bottom middle: merg
control antibodies. Scale bars: white, 10 mm; yellow, 5 mm. Abbreviatabove background noise in the region of the heart,
but not in other organs, throughout the ﬁrst 48 h in
ischemic animals and was signiﬁcantly higher than
for sham rats at all time-points (p < 0.01) (Online
Fig. 2B). Although absolute values for total Fluc
radiance diminished over time (IR group: 71.1 
29.0  104 photons/s at 6 h, 19.3  6.0  104
photons/s at 24 h, 11.9  2.7  104 photons/s at 48
h; p < 0.001), the relative difference in cardiac Fluc
signal was highest between the ischemic and sham
groups at 48 h (11.9 2.7 104 photons/s vs. 2.2
0.5  104 photons/s; p < 0.01) (Figs. 3A and 3B,
Online Fig. 2B). This increase in Fluc in the IR
setting was conﬁrmed after the signal was corrected
for number of cells with Rluc, which was measured
by using ex vivo luminometry of LV homogenates,
because an in vivo signal could not be reliably imaged
due to tissue attenuation (Fluc:Rluc ratio 0.026 
0.004 for IR vs. 0.011  0.003 for sham at 48 h;
p < 0.05) (Fig. 3C, Online Fig. 2B). Tissue im-
munoﬂuorescent staining was also used to verify that
transplanted MSCs (transfected to constitutivelyivo
SC transfer in the different experimental groups. (B) Results for total
ay 2. (C) Day 2 results for left ventricular Fluc activity by ex vivo
¼ 7; sham controls, n ¼ 8; IR Tempol, n ¼ 5; IR null vector, n ¼ 3.
–Fluc MSCs. (D) Immunoﬂuorescence showing expression of NAD(P)H
in IR myocardium 2 days after delivery. Top row: low magniﬁcation;
ed image for sham myocardium; bottom right: immunoglobulin G
ions as in Figures 1 and 2.
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800express green ﬂuorescent protein) did in fact express
NAD(P)H p67phox 48 h after administration to
ischemic (but not sham) myocardium (Fig. 3D).
MSCs transfected with a Null-Fluc vector dis-
played very low levels of Fluc activity (1.5  0.3 
104 photons/s by BLI at 48 h) (Figs. 3A to 3C),
underscoring the speciﬁcity of the detected oxidative
stress signal. Furthermore, treatment of MSCs with
5 mmol/l of tempol for 24 h before delivery to IR
animals markedly attenuated the Fluc signal to
levels similar to those in shams (3.7  0.7  104
photons/s at 48 h). This ﬁnding corroborated the
in vitro observation that expression of Fluc could be
used not only to detect different levels of oxidative
stress but also to monitor changes in the biology
of transplanted cells (e.g., after an antioxidant
intervention).
D I SCUSS ION
In this proof-of-principle study, we validated a
pathway-speciﬁc reporter gene approach for
detecting oxidative stress in cells after their transfer
to ischemic myocardium. Using the NAD(P)H
p67phox promoter expressing Fluc, we were able to
demonstrate Fluc signal in MSCs transplanted to
ischemic myocardium. Moreover, this study pro-
vides preliminary evidence that this novel oxidative
stress sensor may be used to monitor the effect of
adjuvant interventions targeted to improve the
biology of transplanted progenitor cells.
A recurring obstacle for cell therapy studies con-
tinues tobe the signiﬁcant loss of viable cells from target
myocardium in the early aftermath of transplantation,
ultimately limiting the scope of therapeutic beneﬁt
(13). Although the immediate retention of cells is
adversely inﬂuenced by mechanical forces during the
delivery process, ongoing attrition and failure of
engraftment are also contributed to by noxious stimuli
in the foreign environment of the recipient heart. This
has been shown to apply for cell delivery into healthy,
intact myocardium but is further accentuated in the
setting of ischemia/infarction, in which a combination
of reduced tissue perfusion and reperfusion injury, in-
ﬂammatory cell inﬁltration, and pro-oxidant factors
incite local release of oxidative free radicals and pro-
duction of ROS, imparting increased oxidative stress to
recently administered cells (9,14).Although the precise
effects of increased oxidative stress on cell survival,
proliferation, differentiation,maturation, andparacrine
function are largely undetermined, they are thought to
depend on variables such as cell type, myocardial dis-
tribution of cell delivery, and severity of the myocardial
pro-oxidant state (15–17). Recently, transcriptomicanalysis has revealed that the overwhelming inﬂuence
of ischemic and inﬂamedmyocardiumonbonemarrow
mononuclear cells early after transplantation is to
trigger survival responses (9). In the case of MSCs,
exposure to ROS (likely depending on level of ROS)
may cause either deleterious or favorable effects
on viability, senescence, and biological function
(7,8,12,18). Furthermore, the importance of the
oxidative status of MSCs has also been highlighted by
showing that its manipulation (e.g. by gene trans-
fection, hypoxic preconditioning, pharmacological
intervention) may protect against apoptosis and
enhance reparative capacity (10,12,19–22).
With our goal of monitoring oxidative stress in
MSCs, we elected to use the Fluc reporter gene
system, which has been a cornerstone of BLI, to
evaluate cell fate in small animal studies (4,15).
Previously, the implementation of reporter gene
labeling has mainly been in the context of using
constitutional promoters, to provide surrogate in-
formation about the number of viable cells retained
in myocardium over different time intervals. Recent
developments in pathway-speciﬁc reporter gene
imaging have begun to allow surveillance of other
biological processes in transplanted cells in vivo,
notably their differentiation along cardiomyocyte
or endothelial lineages by using conditional pro-
moters, such as cardiac sodium–calcium exchanger-1
(Ncx-1) or Tie2, respectively (5,6).
In selecting an appropriate promoter that would
trigger Fluc expression in “stressed” MSCs, our
choice of NAD(P)H p67phox was based on its
reliable up-regulation when MSCs were exposed to
hypoxic (12) or low-serum conditions, accompanied
by increased production of ROS. Although the use
of NAD(P)H p67phox to regulate reporter gene
expression may not necessarily reﬂect activation of
alternative ROS pathways (e.g., xanthine oxidase,
mitochondrial P450 cytochromes), its validity was
supported here by the ability to detect increased Fluc
signal in cells exposed to pro-oxidant conditions both
in vitro and in vivo. Compared with IR, Fluc in-
tensity was considerably lower in sham animals, in
keeping with the expectation that their myocardium
would provide a less hostile milieu for transplanted
cells, based on lower tissue expression of pro-oxidant,
pro-inﬂammatory, and apoptotic markers. Impor-
tantly, immunostaining revealed that MSCs retained
within ischemic myocardium did indeed express
NAD(P)H p67phox, conﬁrming the biological
changes of MSCs in the in vivo setting of IR.
Furthermore, the correction of Fluc signal for viable
cell number by using a second reporter gene (CMV-
Rluc) clearly demonstrated that the up-regulation of
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801NAD(P)H p67phox–Fluc in IR animals compared
with sham animals was not merely due to retention of
higher cell numbers in ischemic tissue. It is worth
noting that measurement of Rluc did require ex vivo
luminometry, as in vivo detection by BLI was
complicated by the fact that Rluc emits blue wave-
length photons (lpeak ¼ 480 nm) when coelenter-
azine is used as its substrate, and these can be strongly
attenuated by the subject’s chest wall. Novel de-
velopments of red-shifted Rluc mutants may allow
better in vivo signal detection in future studies (23).
One of the main challenges for pathway-speciﬁc
reporter gene labeling is the relatively weak activity
inherent in transcriptional targeting with most
conditional promoters. Although the use of an
ampliﬁcation strategy (TSTA) necessitated complex
vector design and testing due to the inclusion of
multiple elements in addition to the promoter and
reporter gene (Fig. 1C), it was a critical component
in this study to achieve detectable Fluc signal in rat
myocardium. Although previous work has demon-
strated that TSTA vectors may achieve profound
ampliﬁcation of weak promoters, including those
that are cardiac speciﬁc (e.g. troponin T, alpha-
myosin heavy chain) (11,24), the current study
provides early in vivo evidence of their utility for
imaging transfected cells in recipient myocardium.
Study limitations. One of the potentially important
applications for a new imaging sensor for cellular
oxidative stress will be to enable surveillance of its
ﬂuctuation over time. This could contribute insights
regarding the optimal therapeutic window for cell
delivery after myocardial injury and reveal critical
intervals during which adjuvant interventions may
help to modify the oxidative status of retained cells.
Unfortunately, a major confounder of the ability to
interpret temporal tends in absolute biological signal
is the rapid and progressive diminution of cell number
from recipient myocardium (3,15). We have also
observed this to be the case in our model system
during separate experiments, in which CMV-Fluc
MSCs were used to follow the time course of their
retention (data not shown). This ﬁnding, along with
the transient nature of the plasmid transfection
strategy used here, is likely to have contributed to the
sharp decline in absolute NAD(P)H p67phox–Fluc
signal observed after cell injection in both the IR and
sham groups (Online Fig. 2). Although we found that
reporter gene expression is maintained in vitro for at
least 2 weeks after transfection, peak signal typically
occurs within the ﬁrst 4 days. In future studies, the
use of stable genomic integration (e.g., by retroviral
vectors, TALE nucleases) of theNAD(P)H p67phox–
Fluc sensor in transplanted cells will be warranted.It should also be recognized that alternative
oxidative stress pathways may be more relevant than
NAD(P)H oxidase for other progenitor cell types
currently under investigation in cardiovascular
studies. Further evaluation and reﬁnement of
oxidative stress imaging will therefore need to
determine optimal stress-related promoters for in-
dividual cell types, as well as for different disease
contexts, including chronic myocardial ischemia and
nonischemic cardiac disease.
Implications and clinical translation. Previous rodent
studies have used constitutive reporter gene imaging
by bioluminescence to address key questions per-
taining to optimal cell type (15), timing interval
(17), and site of administration (16). Their ﬁndings
have provided novel insights to assist in the plan-
ning and design of clinical stem cell studies. Simi-
larly, in the case of an oxidative stress sensor, we
anticipate that BLI will enable rapid and high
throughput interrogation of biological interactions
between transplanted cells and their recipient envi-
ronment to help screen and hone cell and tissue
engineering strategies in preclinical models, before
guiding their translation to the clinical realm. In
the context of MSCs, such optimization strategies
may include the use of immunoenriched, genet-
ically engineered, preconditioned, or cardiopoiesis-
directed MSCs (10). Furthermore, conditional
promoters, such as NAD(P)H p67phox, may even be
implemented in a “theranostics approach” (11),
whereby imaging and therapeutic applications are
combined by using bidirectional systems to regulate
the selective expression of linked transgenes (e.g.,
reporter and therapeutic genes) in transfected cells.
Despite its many advantages for cell tracking in
rodents, the lack of spatial resolution and tissue depth
penetration ofBLIprecludes its use in human subjects.
Thus, the direct implementation of oxidative stress
reporter gene imaging in large animal and clinical
studies will necessitate the replacement of Fluc with
reporter genes speciﬁcally designed for clinical imaging
modalities (3). Owing to its superior cell detection
sensitivity (femtomolar range) and radiochemical
ﬂexibility, it is likely that positron emission tomogra-
phy (PET) will be better placed for initial clinical
translation than either single-photon emission com-
puter tomography or magnetic resonance imaging,
although hybrid PET–magnetic resonance imaging
or PET–computed tomography will be useful for
achieving optimal balance of oxidative stress detection
and anatomic resolution. To this end, porcine studies
have already demonstrated the feasibility and validity
of PET-based (e.g., 18F-FHBG PET) detection of
constitutive reporter gene expression (e.g., herpes
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802simplex thymidine kinase) in retrovirally transfected
MSCs after myocardial delivery (25–27).
CONCLUS IONS
This study demonstrates the feasibility of using
pathway-speciﬁc reporter gene labeling to monitor
the oxidative stress of transplanted progenitor cells,providing a novel platform to help optimize the use
of cell therapies.
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